Photo from Rami Komrokji/Twitter
Feb 9, 2024, 05:19
Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression
Quoting Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Centre and Research Institute, on X/Twitter:
”Early View / Hematologica our paper addressing pattern of LRMDS progression. Majority don’t progress and molecular signatures can identify direct AML progression.”
Source: Rami Komrokji/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14